23andMe bankruptcy sparks concerns over data privacy
Source: SeekingAlpha
2025-03-25 11:48:26 ET
More on 23andMe
- 23andMe files for bankruptcy, CEO and co-founder Wojcicki resigns
- 23andMe gains after CEO Wojcicki makes revised $2.94/share offer with CVR
- Seeking Alpha’s Quant Rating on 23andMe
- Historical earnings data for 23andMe
- Financial information for 23andMe
Read the full article on Seeking Alpha
For further details see:
23andMe bankruptcy sparks concerns over data privacy
GlaxoSmithKline PLC
NASDAQ: GSK
GSK Trading
-0.42% G/L:
$53.94 Last:
2,007,718 Volume:
$54.48 Open:
GSK Latest News
March 13, 2026 11:44:00 am
GSK's RSV Vaccine, AREXVY, Approved in US for Expanded Age Indication in Adults Aged 18-49 Years at Increased Risk
February 23, 2026 01:13:00 pm
Bora Pharmaceuticals and GSK Sign $250M Five Year Global Manufacturing Contract
GSK Stock Data
$120,291,791,432
2,019,018,428
0.4%
538
N/A
Pharmaceuticals
Healthcare
GB
London
